Rich Pharmaceuticals, Inc. Rich, a cancer therapeutics development company announced that it has entered into an investment agreement up to $4.5 Million with Macallan Partners, LLC headquartered in White Plains, NY. The investment commences under the Macallan Partners, LLC Agreement filed under Form S-1 and recently was declared effective by the Securities and Exchange Commission.
Read article Rich Pharmaceuticals Announces Up To $4.5 Million Finance Deal To...»
Read article Rich Pharmaceuticals Announces Up To $4.5 Million Finance Deal To...»
No comments:
Post a Comment